Prothrombotic state in glioblastoma multiforme: An evaluation of the procoagulant activity of circulating microparticles

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 225-231

  Sartori, Maria Teresa ^a   Della Puppa, Alessandro ^a   Ballin, Andrea ^a   Saggiorato, Graziella ^a   Bernardi, Daniela ^a   Padoan, Andrea ^a   Scienza, Renato ^a   D'Avella, Domenico ^a   Cella, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Brain tumors; Glioblastoma multiforme; Microparticles; Prothrombotic state; Venous thromboembolism

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; PROSPECTIVE STUDY; PROTHROMBOTIC STATE; THROMBOGENESIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; CELL-DERIVED MICROPARTICLES; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOEMBOLISM;

EID: 80052774696     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0462-8     Document Type: Article

References (27)

1. T Wun RH White 2009 Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors Cancer Invest 27 63 74 19291526 10.1080/07357900802656681
2. AA Khorana 2010 Venous thromboembolism and prognosis in cancer Thromb Res 125 490 493 20097409 10.1016/j.thromres.2009.12.023 1:CAS:528: DC%2BC3cXmslSit78%3D
3. A Falanga 2009 The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment Cancer Invest 27 105 115 19160098 10.1080/07357900802563028 1:CAS:528:DC%2BD1MXhsFWmtb4%3D
4. C Milsom J Rak 2007 Tissue factor and cancer Pathophysiol Haemost Thromb 36 160 176 10.1159/000175154 1:CAS:528:DC%2BD1MXhtFOmu78%3D
5. J Zhang J Ding X Zhang X Shao Z Hao 2005 Regulation of vascular endothelial growth factor production and angiogenesis by tissue factor in SGC-7901 gastric cancer cells Cancer Biol Ther 4 769 772 15846107 10.4161/cbt.4.7.1871 1:CAS:528:DC%2BD28XjtlWktb0%3D (Pubitemid 41351178)
6. JI Zwicker BC Furie B Furie 2007 Cancer-associated thrombosis Crit Rev Oncol Hematol 62 126 136 17293122 10.1016/j.critrevonc.2007.01.001 (Pubitemid 46575277)
7. A Aharon B Brenner 2009 Microparticles, thrombosis and cancer Best Pract Res Clin Haematol 22 61 69 19285273 10.1016/j.beha.2008.11.002 1:CAS:528:DC%2BD1MXjt1agsLg%3D
8. P Davizon JA Lòpez 2009 Microparticles and thrombotic disease Curr Opin Hematol 16 334 341 19606028 10.1097/MOH.0b013e32832ea49c
9. CBTRUS (2009) 2009-2010 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in eighteen states in 2002-2006. Central Brain Tumor Registry of the United States, Hinsdale, IL. www.cbtrus.org
10. R Stupp ME Hegi WP Mason, et al. 2009 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459 466 19269895 10.1016/S1470-2045(09)70025-7 1:CAS:528:DC%2BD1MXlsVKhs74%3D
11. LC Marras WH Geerts JR Perry 2000 The risk of venous thromboembolism is increased throughout the course of malignant glioma Cancer 89 640 646 10931464 10.1002/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E 1:STN:280:DC%2BD3cvgt1aqsg%3D%3D (Pubitemid 30640111)
12. JT Semrad R O'Donnel T Wun, et al. 2007 Epidemiology of venous thromboembolism in 9489 patients with malignant glioma J Neurosurg 106 601 608 17432710 10.3171/jns.2007.106.4.601 (Pubitemid 46536455)
13. M Franchini M Montagnana G Targher F Manzato G Lippi 2007 Pathogenesis, clinical and laboratory aspects of thrombosis in cancer J Thromb Thrombolysis 24 29 38 17396228 10.1007/s11239-007-0028-6 (Pubitemid 46831561)
14. C Colin B Voutsinos-Porche I Nanni, et al. 2009 High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas Acta Neuropathol 118 745 754 19774387 10.1007/s00401-009-0592-2 1:CAS:528:DC%2BD1MXhsVWrur3P
15. Y Rong VE Belozerov C Tucker-Burden, et al. 2009 Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein 1 transcriptional activity Cancer Res 69 2540 2549 19276385 10.1158/0008-5472.CAN-08-1547 1:CAS:528:DC%2BD1MXjtFyqu78%3D
16. PS Wells DR Anderson J Bormanis, et al. 1997 Value of assessment of pretest probability of deep-vein thrombosis in clinical management Lancet 350 1795 1798 9428249 10.1016/S0140-6736(97)08140-3 1:STN:280:DyaK1c%2FovFymsg%3D%3D (Pubitemid 28036513)
17. PS Wells DR Anderson M Rodger, et al. 2000 Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer Thromb Haemost 83 416 420 10744147 1:CAS:528:DC%2BD3cXisVSqurk%3D (Pubitemid 30148355)
18. R Simanek R Vormittag M Hassler, et al. 2007 Venous thromboembolism and survival in patients with high-grade glioma Neuro Oncol 9 89 95 17327573 10.1215/15228517-2006-035 (Pubitemid 46580310)
19. RA Rodas RA Fenstermaker PE McKeever, et al. 1998 Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report J Neurosurg 89 200 205 9688113 10.3171/jns.1998.89.2.0200 1:STN:280:DyaK1czltFequw%3D%3D (Pubitemid 28346137)
20. DC Walsh AK Kakkar 2001 Thromboembolism in brain tumors Curr Opin Pulm Med 7 326 331 11584184 10.1097/00063198-200109000-00013 1:STN:280: DC%2BD3MrjsFWhsA%3D%3D (Pubitemid 32929690)
21. JI Zwicker HA Liebman D Neuberg, et al. 2009 Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 6830 6840 19861441 10.1158/1078-0432.CCR-09- 0371 1:CAS:528:DC%2BD1MXhtl2ktLzJ
22. ME Tesselaar FP Romijn IK Van Der Linden FA Prins RM Bertina S Osanto 2007 Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 520 527 17166244 10.1111/j.1538-7836.2007.02369.x 1:CAS:528:DC%2BD2sXktFCju7Y%3D (Pubitemid 46680685)
23. G Hron M Kollars H Weber, et al. 2007 Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 119 123 17200778 1:CAS:528:DC%2BD2sXhvVOjsLg%3D (Pubitemid 46242392)
24. J Skog T Wurdinger S van Rijn, et al. 2008 Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 1470 1476 19011622 10.1038/ncb1800 1:CAS:528:DC%2BD1cXhsVentbfI
25. ME Tesselaar FP Romijn IK van der Linden RM Bertina S Osanto 2009 Microparticle associated tissue factor activity in cancer patients with and without thrombosis J Thromb Haemost 7 1421 1423 19500241 10.1111/j.1538-7836. 2009.03504.x 1:CAS:528:DC%2BD1MXhtFGks77P
26. DA Manly J Wang SL Glover, et al. 2010 Increased microparticle tissue factor activity in cancer patients with venous thromboembolism Thromb Res 125 511 512 19854471 10.1016/j.thromres.2009.09.019 1:CAS:528:DC%2BC3cXmslSit7s%3D
27. AA Khorana CW Francis KE Menzies, et al. 2008 Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J Thromb Haemost 6 1983 1985 18795992 10.1111/j.1538-7836.2008.03156.x 1:CAS:528:DC%2BD1cXhsVyqs7rM